Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study
Movement Disorders · 2023-12 · 38 (12) · 2241-2248
DOI: 10.1002/mds.29617 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Movement Disorders, online erschienen am 26.09.2023. Verfasst von Alessio Di Fonzo und 30 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Section, Department of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Background and Objective Early‐onset Parkinson's disease (EOPD) commonly recognizes a genetic basis; thus, patients with EOPD are often addressed to diagnostic testing based on next‐generation sequencing (NGS) of PD‐associated multigene panels. However, NGS interpretation can be challenging in a diagnostic setting, and few studies have addressed this issue so far.
Methods
We retrospectively collected data from 648 patients with PD with age at onset younger than 55 years who underwent NGS of a minimal shared panel of 15 PD‐related genes, as well as PD‐multiplex ligation‐dependent probe amplification in eight Italian diagnostic laboratories. Data included a minimal clinical dataset, the complete list of variants included in the diagnostic report, and final interpretation (positive/negative/inconclusive). Patients were further stratified based on age at onset ≤40 years (very EOPD, n = 157). All variants were reclassified according to the latest American College of Medical Genetics and Genomics criteria. For classification purposes, PD‐associated GBA1 variants were considered diagnostic.
Results
In 186 of 648 (29%) patients, the diagnostic report listed at least one variant, and the outcome was considered diagnostic (positive) in 105 (16%). After reanalysis, diagnosis changed in 18 of 186 (10%) patients, with 5 shifting from inconclusive to positive and 13 former positive being reclassified as inconclusive. A definite diagnosis was eventually reached in 97 (15%) patients, of whom the majority carried GBA1 variants or, less frequently, biallelic PRKN variants. In 89 (14%) cases, the genetic report was inconclusive.
Conclusions
This study attempts to harmonize reporting of PD genetic testing across several diagnostic labs and highlights current difficulties in interpreting genetic variants emerging from NGS‐multigene panels, with relevant implications for counseling. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroscience Section, Department of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, Milan, Italy.
- Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy.
- School of Medicine and Surgery, Milan Center for Neuroscience, University of Milan-Bicocca, Milan, Italy.
- Foundation IRCCS San Gerardo dei Tintori, Monza, Italy.
- IRCCS Mondino Foundation, Pavia, Italy.
- IRCCS Humanitas Research Hospital, Milan, Italy.
ORCID-Profile: Alessio Di Fonzo, Pietro Cortelli, Enza Maria Valente
Förderung
- Ministero della Salute
Zitieren
APA
Di Fonzo, A., Percetti, M., Monfrini, E., Palmieri, I., Albanese, A., Avenali, M., Bartoletti-Stella, A., Blandini, F., Brescia, G., Calandra-Buonaura, G., Campopiano, R., Capellari, S., Colangelo, I., Comi, G. P., Cuconato, G., Ferese, R., Galandra, C., Gambardella, S., Garavaglia, B., …, & PARKNET study group (2023). Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study. Movement Disorders, 38(12), 2241-2248. https://doi.org/10.1002/mds.29617
Vancouver
Di Fonzo A, Percetti M, Monfrini E, Palmieri I, Albanese A, Avenali M, et al. Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study. Movement Disorders. 2023;38(12):2241-2248. doi:10.1002/mds.29617
BibTeX
@article{DiFonzo2023,
author = {Di Fonzo, Alessio and Percetti, Marco and Monfrini, Edoardo and Palmieri, Ilaria and Albanese, Alberto and Avenali, Micol and Bartoletti-Stella, Anna and Blandini, Fabio and Brescia, Gloria and Calandra-Buonaura, Giovanna and Campopiano, Rosa and Capellari, Sabina and Colangelo, Isabel and Comi, Giacomo Pietro and Cuconato, Giada and Ferese, Rosangela and Galandra, Caterina and Gambardella, Stefano and Garavaglia, Barbara and Gaudio, Andrea and Giardina, Emiliano and Invernizzi, Federica and Mandich, Paola and Mineri, Rossana and Panteghini, Celeste and Reale, Chiara and Trevisan, Lucia and Zampatti, Stefania and Cortelli, Pietro and Valente, Enza Maria and PARKNET study group, PARKNET study group},
title = {Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study},
journal = {Movement Disorders},
year = {2023},
volume = {38},
number = {12},
pages = {2241--2248},
doi = {10.1002/mds.29617}
}
EUVIMED